Press Releases

Lexicon Pharmaceuticals Initiates Patient Dosing in a Phase 1 Study of LX9211	Sep 27, 2017
European Commission Approves Xermelo® (Telotristat ethyl) for the Treatment of Carcinoid Syndrome Diarrhea in Combination with Somatostatin Analog Therapy	Sep 19, 2017
Lexicon Pharmaceuticals to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference	Sep 18, 2017
New England Journal of Medicine Publishes Data from Phase 3 inTandem3 Study of Sotagliflozin in Patients with Type 1 Diabetes	Sep 13, 2017
Lexicon Pharmaceuticals Reports Positive Pooled Continuous Glucose Monitoring Data from Pivotal Phase 3 Intandem1 and inTandem2 Studies of Sotagliflozin	Sep 08, 2017
Lexicon Pharmaceuticals to Present at the Bank of America Merrill Lynch 2017 Global Healthcare Conference	Sep 07, 2017
Lexicon Pharmaceuticals Announces Four Data Presentations at the European Society of Medical Oncology 2017 Congress	Sep 07, 2017
Lexicon Pharmaceuticals to Present New Clinical Data at the European Association for the Study of Diabetes 53rd Annual Meeting	Sep 05, 2017
Lexicon Pharmaceuticals Reports Additional Positive Data from Pivotal Phase 3 Intandem2 Study of Sotagliflozin	Aug 15, 2017
Lexicon Pharmaceuticals to Present at 2017 Wedbush Pacgrow Healthcare Conference	Aug 03, 2017